ArticleMolecular therapy : the journal of the American Society of Gene Therapy2024

Tumor-intrinsic CDC42BPB confers resistance to anti-PD-1 immune checkpoint blockade in breast cancer.

Ravindra Pramod Deshpande et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.